FARN:LON
Faron Pharmaceuticals Oy
36,60 GBX
arrow_upward
+0,27%(+0,100) 1D
12 ოქტ, 16:30:00 GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FARN...
Open
35,06 GBX
High
38,00 GBX
Low
35,00 GBX
Mkt. cap
74,16 მლნ.
Avg. vol.
42,63 ათ.
Volume
7,06 ათ.
52-wk high
193,58 GBX
52-wk low
34,00 GBX
EPS
-0,10 GBX
Shares outstanding
31,03 მლნ.
No. of employees
36
Open
35,06 GBX
High
38,00 GBX
Low
35,00 GBX
Mkt. cap
74,16 მლნ.
Avg. vol.
42,63 ათ.
Volume
7,06 ათ.
52-wk high
193,58 GBX
52-wk low
34,00 GBX
EPS
-0,10 GBX
Shares outstanding
31,03 მლნ.
No. of employees
36
News stories
From web sources and news partners
Foreign Policy Journal
·
11 წუთის წინ
SoundHound AI (NASDAQ: SOUN) Slides 46% In 2026 As Cash Burn Outpaces Revenue Growth
TradingView
·
26 წუთის წინ
S&P 500 expected to see 25% EPS growth as earnings kick off
Seeking Alpha
·
41 წუთის წინ
S&P 500 surpasses 1,000 trading days without a new 52-week low
Profile
Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland.
The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the development of treatments for acute organ traumas, vascular damage and cancer immunotherapy.
Its lead product Traumakine has been developed to treat acute respiratory distress syndrome. It is currently undergoing international phase III clinical trials after an open-label, early-phase trial showed promising results in the treatment patients with ARDS. The drug is known to function by enhancing lung CD73 expression and increasing production of anti-inflammatory adenosine, such that vascular leaking and escalation of inflammation are reduced. The U.S. Food and Drug Administration FDA has accepted the proposed protocol design for the next Traumakine study in March 2020. The phase III study is a comparison of efficacy in the treatment of patients with ARDS.
In 2020 Traumakine was selected to take part in the WHO Solidarity trial and REMAP-CAP trials to find drugs for the symptoms of Covid_19. Wikipedia
About Faron Pharmaceuticals Oy